IDiyas

For the Inventor, By the Inventor

Princeton Junction, NJ, United States of America

Yuping Qiu

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 148(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1998 - 2000)
  • Windsor, CT (US) (2005)
  • Glastonbury, CT (US) (2005 - 2012)
  • Princeton Junction, NJ (US) (2010 - 2019)

Company Filing History:

goldMedal17 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
silverMedal4 out of 2,595 
 
University of Pennsylvania
 patents

Years Active: 1998-2019

Loading Chart...
Loading Chart...
21 patents (USPTO):
1. 10494400 - Hepatitis C virus inhibitors (2019-12-03),
2. 8828691 - Process for resolving cyclopropyl diesters (2014-09-09),
3. 8735398 - Hepatitis C virus inhibitors (2014-05-27),
4. 8383094 - Hepatitis C virus inhibitors (2013-02-26),
5. 8362020 - Hepatitis C virus inhibitors (2013-01-29),
6. 8143288 - Inhibitors of HCV replication (2012-03-27),
7. 7968718 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2011-06-28),
8. 7906655 - Hepatitis C virus inhibitors (2011-03-15),
9. 7723536 - Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof (2010-05-25),
10. 7683171 - [object Object] (2010-03-23),
11. 7601715 - Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein (2009-10-13),
12. 7456194 - [object Object] (2008-11-25),
13. 7329668 - Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same (2008-02-12),
14. 7176214 - Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same (2007-02-13),
15. 7071333 - Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same (2006-07-04),

Title: Innovations and Contributions of Yuping Qiu

Introduction

Yuping Qiu, a prominent inventor based in Princeton Junction, NJ, has significantly contributed to the field of pharmaceutical sciences. With a remarkable portfolio of 21 patents, his work focuses on developing innovative treatments for various viral infections and advancing chemical methodologies.

Latest Patents

Among his latest innovations, Qiu developed methods for creating Hepatitis C virus inhibitors, highlighting the significance of asunaprevir as an effective treatment for Hepatitis C virus (HCV) infection. Additionally, he has disclosed a process for resolving cyclopropyl diesters, which emphasizes a method for the stereospecific hydrolysis of racemic 1,1-dialkyloxycarbonylcyclopropanes, further showcasing his expertise in organic chemistry.

Career Highlights

Yuping Qiu has had a distinguished career in both academia and industry. He has worked with Bristol-Myers Squibb Company, where he played a critical role in drug development. He also served at the University of Pennsylvania, contributing to research and education in pharmaceutical sciences. His work has not only led to numerous patents but has also paved the way for innovative treatments that impact public health.

Collaborations

Throughout his career, Qiu has collaborated with notable colleagues, including Makonen Belema and Xuejie Yang. These partnerships have facilitated shared knowledge and insights, driving forward the progress of their research and innovations.

Conclusion

Yuping Qiu's dedication to innovation and his substantial contributions to the field of pharmaceuticals exemplify the impact of committed inventors on human health. His numerous patents reflect a deep-seated commitment to addressing pressing medical challenges and advancing chemical methodologies, making him a key figure in the landscape of modern science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…